mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.1 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |